Skip to content

The Actual News

Stay informed without the news wearing you out.

Major Cancer Study Targets 75,000 Samples—What Scientists Hope to Find

Major Cancer Study Targets 75,000 Samples—What Scientists Hope to Find

Summary

Researchers plan to sequence nearly 75,000 samples from the Multiethnic Cohort to search for rare genetic variants linked to cancer risk. They hope the findings may eventually help doctors tailor screening, but any new risk associations would need confirmation and evidence that extra screening benefits patients.

Key Facts

  • Regeneron Genetics Center will fund and conduct whole exome sequencing of de-identified samples.
  • Whole exome sequencing examines the protein-coding parts of DNA and can help identify rare genetic variants.
  • The Multiethnic Cohort has followed adults in Southern California and Hawaii for more than 25 years.
  • The cohort began recruiting participants in 1993 and includes health, diet, and lifestyle data from more than 215,000 people.
  • Participants include African American, Japanese American, Latin American, Native Hawaiian, and white people.
  • Researchers aim to find rare variants that influence cancer risk, including variants found more often in ancestry groups under-represented in genetic research.
  • Researchers say a rare variant alone does not prove it is harmful or justify changing screening recommendations.
  • Sequencing is expected to finish in 2027, after which researchers will analyze the results.
Read the Full Article

This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.

The week's biggest stories, one calm email every Monday.